Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation

Autor: Lip, Gregory Y.H., Lanitis, Tereza, Kongnakorn, Thitima, Phatak, Hemant, Chalkiadaki, Corina, Liu, Xianchen, Kuznik, Andreas, Lawrence, Jack, Dorian, Paul
Zdroj: In Clinical Therapeutics 1 November 2015 37(11):2476-2488
Databáze: ScienceDirect